glp-1 agonist review Frontiers GLP-1 receptor agonists show promise

In this article we look at the history of GLP-1 receptor agonists, how they work, and the impact of them going viral as 'miracle treatments'.

The answer is yes

When oxidative demand approaches the regenerative capacity of nicotinamide adenine dinucleotide (NAD)/ nicotinamide adenine dinucleotide phosphate (NADPH

The aim of this narrative review is to critically assess the renoprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing albuminuria among patients with type 2 diabetes mellitus within the framework of personalized ...

Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.